Nonclassical Axis of the Renin-Angiotensin System and Neprilysin: Key Mediators That Underlie the Cardioprotective Effect of PPAR-Alpha Activation during Myocardial Ischemia in a Metabolic Syndrome Model
The activation of the renin-angiotensin system (RAS) participates in the development of metabolic syndrome (MetS) and in heart failure. PPAR-alpha activation by fenofibrate reverts some of the effects caused by these pathologies. Recently, nonclassical RAS components have been implicated in the path...
Saved in:
Main Authors: | María Sánchez-Aguilar, Luz Ibarra-Lara, Leonardo del Valle-Mondragón, Elizabeth Soria-Castro, Juan Carlos Torres-Narváez, Elizabeth Carreón-Torres, Alicia Sánchez-Mendoza, María Esther Rubio-Ruíz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2020/8894525 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rosiglitazone, a Ligand to PPARγ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation
by: María Sánchez-Aguilar, et al.
Published: (2019-01-01) -
Angiotensin-Neprilysin Inhibitor Therapy: A Retrospective Chart Study
by: Roda Plakogiannis, et al.
Published: (2025-02-01) -
The Prorenin and (Pro)renin Receptor: New Players in the Brain Renin-Angiotensin System?
by: Wencheng Li, et al.
Published: (2012-01-01) -
Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial
by: Rolf Wachter, et al.
Published: (2020-06-01) -
Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
by: P. Stiefel, et al.
Published: (2011-01-01)